14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of XGN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Wednesday for Exagen Inc.
(Updated on Apr 24, 2024)

Sell candidate since Mar 19, 2024 Loss -10.39% PDF

The Exagen Inc. stock price fell by -1.43% on the last day (Wednesday, 24th Apr 2024) from $1.40 to $1.38. During the last trading day the stock fluctuated 2.91% from a day low at $1.37 to a day high of $1.41. The price has fallen in 5 of the last 10 days and is down by -6.12% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -9 thousand shares and in total, 3 thousand shares were bought and sold for approximately $3.61 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.32 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -34.19% during the next 3 months and, with a 90% probability hold a price between $0.87 and $1.12 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

XGN Signals & Forecast

There are mixed signals in the stock today. The Exagen Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.40 and $1.58. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 0.730%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Exagen Inc. stock

Exagen Inc. finds support from accumulated volume at $1.37 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0398 between high and low, or 2.91%. For the last week the stock has had daily average volatility of 5.13%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (XGN) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Exagen Inc. to open at $1.39, and during the day (based on 14 day Average True Range), to move between $1.27 and $1.49, which gives a possible trading interval of +/-$0.109 (+/-7.88%) up or down from last closing price. If Exagen Inc. takes out the full calculated possible swing range there will be an estimated 15.75% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.37 (0.72%) than the resistance at $1.54 (11.59%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Exagen Inc. stock A Buy?

Exagen Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.051 Sell Candidate Unchanged

Predicted Opening Price for Exagen Inc. of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$1.39 ( 0.478%) $1.38

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for XGN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.43 3.36 %
R2 1.41 2.26 %
R1 1.40 1.58 %
Current price: 1.38
Support S1 1.37 -0.623 %
S2 1.36 -1.30 %
S3 1.35 -2.41 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.67 21.01 %
R2 1.61 16.67 %
R1 1.54 11.59 %
Current price 1.38
Support S1 1.37 -0.725%
S2 0 .
S3 0 .

FAQ

What is the symbol for Exagen Inc. Stock and on which exchange is it traded?
The symbol for Exagen Inc. is XGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Exagen Inc. Stock?
Exagen Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Exagen Inc. Stock?
Exagen Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Exagen Inc. Stock.

What's the current price of Exagen Inc. Stock?
As of the end of day on the Apr 24, 2024, the price of an Exagen Inc. (XGN) share was $1.38.

What is the 52-week high and low for Exagen Inc. Stock?
The 52-week high for Exagen Inc. Stock is $3.92 and the 52-week low is $1.30.

What is the market capitalization of Exagen Inc. Stock?
As of the Apr 24, 2024, the market capitalization of Exagen Inc. is 24.13M.

When is the next earnings date for Exagen Inc.?
The upcoming earnings date for Exagen Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Exagen Inc.

Exagen. Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables diff... XGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT